IDXX
Idexx Laboratories
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: IDXX
- PE Ratio
The PE ratio for Idexx Laboratories stock stands at 39.83 as of Jun 22, 2026. The calculation is based on the latest EPS of $13.7 and the stock price of $545.73 per share. A decrease of 15% has been observed in the PE ratio compared to its average of 46.7 of the last four quarters.
IDXX PE ratio history
Over the last ten years, the average PE ratio of Idexx Laboratories has been 53.71. The current 39.83 P/E ratio is 26% lower than the historical average. Looking back at the last ten years, IDXX's PE ratio peaked in the Dec 2021 quarter at 75.34, with a price of $658.46 and an EPS of $8.74. The Dec 2024 quarter marked the lowest point at 38.39, with a price of $413.44 and an EPS of $10.77.
Idexx Laboratories PE ratio by year
Maximum annual increase: 39.49% in 2020
Maximum annual decrease: -33.32% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 51.37 | 33.81% | $676.53 | $13.17 |
| 2024 | 38.39 | -29.66% | $413.44 | $10.77 |
| 2023 | 54.58 | 8.64% | $555.05 | $10.17 |
| 2022 | 50.24 | -33.32% | $407.96 | $8.12 |
| 2021 | 75.34 | 2.8% | $658.46 | $8.74 |
| 2020 | 73.29 | 39.49% | $499.87 | $6.82 |
| 2019 | 52.54 | 22.59% | $261.13 | $4.97 |
| 2018 | 42.86 | -17.78% | $186.02 | $4.34 |
| 2017 | 52.13 | 9.79% | $156.38 | $3 |
| 2016 | 47.48 | 34.77% | $117.27 | $2.47 |
| 2015 | 35.23 | -13.5% | $72.92 | $2.07 |
| 2014 | 40.73 | 35.54% | $74.14 | $1.82 |
| 2013 | 30.05 | 4.92% | $53.19 | $1.77 |
| 2012 | 28.64 | 6.43% | $46.4 | $1.62 |
| 2011 | 26.91 | -4.37% | $38.48 | $1.43 |
Idexx Laboratories PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 41.01 | -20.17% | $561.89 | $13.7 |
| Dec 2025 | 51.37 | 2.27% | $676.53 | $13.17 |
| Sep 2025 | 50.23 | 13.51% | $638.89 | $12.72 |
| Jun 2025 | 44.25 | 15.05% | $536.34 | $12.12 |
| Mar 2025 | 38.46 | 0.18% | $419.95 | $10.92 |
| Dec 2024 | 38.39 | -20.44% | $413.44 | $10.77 |
| Sep 2024 | 48.25 | 0.92% | $505.22 | $10.47 |
| Jun 2024 | 47.81 | -7.65% | $487.2 | $10.19 |
| Mar 2024 | 51.77 | -5.15% | $539.93 | $10.43 |
| Dec 2023 | 54.58 | 23.71% | $555.05 | $10.17 |
| Sep 2023 | 44.12 | -16.28% | $437.27 | $9.91 |
| Jun 2023 | 52.7 | -11.47% | $502.23 | $9.53 |
| Mar 2023 | 59.53 | 18.49% | $500.08 | $8.4 |
| Dec 2022 | 50.24 | 22.75% | $407.96 | $8.12 |
| Sep 2022 | 40.93 | -8.39% | $325.8 | $7.96 |
IDXX Price vs fair value
IDXX average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
IDXX's current PE ratio is lower than its 3, 5 and 10-year averages.
PE comparison
Idexx Laboratories's price to earnings (P/E) of 39.83 is higher than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 24.1, Idexx Laboratories's price to earnings (P/E) is 65% higher.
IDXX PE vs peers
In comparison to its peer WOOF, IDXX's PE ratio is lower, but it is higher than TMO's and ABT's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| HSIC Henry Schein Inc | 24.12 | $9.15B |
| ABT Abbott Laboratories | 25.18 | $157.43B |
| TMO Thermo Fisher Scientific Inc | 25.49 | $172.59B |
| IDXX Idexx Laboratories Inc | 39.67 | $42.87B |
| WOOF Petco Health & Wellness Company Inc | 125 | $808.39M |
| NEOG Neogen Corp | N/A | $1.94B |
Frequently asked questions
What is Idexx Laboratories's PE ratio?
The price to earnings ratio for IDXX stock as of Jun 22, 2026, stands at 39.83.
What is the 3-year average PE ratio for Idexx Laboratories (IDXX)?
The 3-year average price to earnings ratio for IDXX stock is 46.91.
What is the 5-year average PE ratio for Idexx Laboratories (IDXX)?
The 5-year average price to earnings ratio for IDXX stock is 52.06.
What is the highest PE ratio for IDXX?
The highest quarterly PE ratio in the last ten years has been 75.34 and it was in the Dec 2021 quarter.
How does the current PE ratio for IDXX compare to its historical average?
IDXX's current price to earnings ratio is 26% below its 10-year historical average.
How is IDXX's PE ratio calculated (Idexx Laboratories PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 22, 2026), Idexx Laboratories's share price is $545.73. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $13.7. Therefore, Idexx Laboratories's PE ratio for today is 39.83. PE RATIO(39.83) = STOCK PRICE($545.73) / TTM EPS($13.7)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.